SCHEMBL9764895

SCHEMBL9764895

CCCC(=O)N(O)CCc1ccc2c(c1)oc1ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
ALOX5 P09917 4/20 0.45
ECE1 P42892 2/20 0.42
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MME P08473 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
GAA P10253 1/20 0.40
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764839 0.86 ECE1 (0.44) NPC1RAB9ASMN1; SMN2ECE1MMP12
SCHEMBL9764922 0.84 ALOX5 (0.49) NPC1RAB9ASMN1; SMN2ALOX5ECE1
SCHEMBL9764821 0.81 KMT2A (0.45) NPC1RAB9ASMN1; SMN2ECE1MMP12
SCHEMBL9764824 0.78 NPC1 (0.43) NPC1RAB9ASMN1; SMN2ECE1MMP12
SCHEMBL21510705 0.78 CYP1A2 (0.53) NPC1RAB9ASMN1; SMN2ECE1MMP12
SCHEMBL9764820 0.78 ALOX5 (0.45) NPC1RAB9ASMN1; SMN2ALOX5CYP1A2
SCHEMBL10561801 0.77 CYP1A2 (0.51) NPC1RAB9ASMN1; SMN2ALOX5ECE1
SCHEMBL10593682 0.76 CYP1A2 (0.43) NPC1RAB9ASMN1; SMN2ECE1MMP12
SCHEMBL28263509 0.75 CYP1A2 (0.58) NPC1RAB9ASMN1; SMN2ECE1MEN1
SCHEMBL9764809 0.75 PLA2G10 (0.40) ALOX5ECE1MMP12MMP13MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0422079-A4 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE 1991-08-21 EP disclosed
EP-0422079-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1991-04-17 EP disclosed
WO-1989012636-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1989-12-28 WO disclosed